Medical Weight Loss for Rochester, New York Residents
Rochester, New York residents get physician-supervised weight loss by telehealth from New Hope Weight Loss: a $119 doctor review, then compounded semaglutide from $166/month or tirzepatide from $233/month.
Physician-supervised GLP-1 programs from $166/month · just $5.50/day, serving Rochester through telehealth from our Costa Mesa, California clinic. Doctor review $119. Over 5,400 patients treated.
Why Rochester Residents Choose New Hope Weight Loss
New Hope Weight Loss is a physician-supervised medical weight loss clinic in Costa Mesa, California that has treated over 5,400 patients since 2020. We serve Rochester, New York through telehealth at some of the most transparent prices anywhere, semaglutide from $166/month and tirzepatide from $233/month · just $7.70/day. No insurance battles, no hidden fees. Care is overseen by Dr. Anjmun Sharma, M.D.
From our Costa Mesa, California practice, we provide Rochester with physician-supervised GLP-1 care entirely by telehealth. Treatment is prescribed only after Dr. Sharma's review, and medication ships discreetly to your door.
Rochester is served entirely by telehealth, so there is no local office to visit and no waiting room. We care for patients throughout Downtown, the East End, Park Avenue, and the greater Finger Lakes region. Spanish-speaking Rochester patients complete the entire program, intake, consultation, and follow-up, in Spanish with our bilingual team.
Like much of New York, many people in Rochester want a physician-supervised weight-loss option without local waitlists or unclear pricing. We accept HSA, FSA, Klarna, and Affirm, with no mandatory membership and no surprise charges for Rochester patients.
GLP-1 Weight Loss Programs Available
Compounded semaglutide, from $166/mo (90-day program $499)
The 90-day Metabolic Reset is our most-chosen plan. Semaglutide shares its active ingredient with Wegovy® and Ozempic®; in trials of the branded drug, patients lost an average of 15-17% of body weight under physician supervision.
Compounded tirzepatide, from $233/mo
Tirzepatide's dual GLP-1/GIP action reached up to 22.5% body-weight loss in trials of the branded medication, the advanced option for Rochester patients.
The physician review is a flat $119, with medication billed separately; HSA, FSA, Klarna, and Affirm are accepted.
How Telehealth Works for Rochester
1. Tell us your history through the quiz or intake form. 2. Dr. Sharma confirms your eligibility by secure video, usually within 48 hours. 3. Your compounded medication arrives at your Rochester address in cold-pack packaging, with ongoing follow-up from the team, all without leaving home.
Frequently Asked Questions, Rochester
How do I get treatment from Rochester?
As a Rochester, New York patient you connect with our Costa Mesa, California clinic by telehealth. Dr. Sharma oversees your plan by secure video and compounded medication ships to your home; eligibility is confirmed during the consultation.
Can I do this without an in-person visit from Rochester?
Yes, it is fully telehealth. Your review, prescription, and follow-up are remote, with medication shipped to Rochester in cold-pack packaging, no lines and no drive.
How much does it cost for Rochester patients?
A $119 physician review, then compounded semaglutide from $166/month or tirzepatide from $233/month (medication separate). HSA, FSA, Klarna, and Affirm are accepted, and there is never a distance surcharge.
What areas of Rochester do you serve?
We serve patients from across Rochester by telehealth, including Downtown, the East End, Park Avenue, and the greater Finger Lakes region.
Who qualifies for the program in Rochester?
Eligibility for Rochester patients is decided by Dr. Sharma during the medical review, based on your health history, current medications, and goals. The $119 visit is not charged if you are not a candidate, and there is no obligation to continue.
New Hope Weight Loss | clinic at 1503 South Coast Drive, Suite 322, Costa Mesa, CA 92626 | (657) 837-3342 | Serving Rochester, New York by telehealth. Telehealth availability and eligibility are confirmed during the medical consultation.
Wegovy® and Ozempic® are registered trademarks of Novo Nordisk A/S. Mounjaro® and Zepbound® are registered trademarks of Eli Lilly and Company. New Hope Weight Loss is not affiliated with or endorsed by these companies. Compounded semaglutide and tirzepatide are prepared by licensed U.S. pharmacies and are not FDA-approved, not brand-identical, and not reviewed by the FDA for safety, effectiveness, or quality.